Rezidivierende klinische Mastitiden bei Milchkühen – Bedeutung und Ursachen

A.-S. Grieger; V. Zoche-Golob; J.-H. Paduch; M. Hoedemaker; V. Krömker

doi:10.1055/s-0038-1623218

Tierärztliche Praxis Ausgabe G: Großtiere / Nutztiere, Table of Contents

Tierarztl Prax Ausg G Grosstiere Nutztiere 2014; 42(03): 156-162
DOI: 10.1055/s-0038-1623218

Übersichtsartikel

Schattauer GmbH

Rezidivierende klinische Mastitiden bei Milchkühen – Bedeutung und Ursachen

Recurrent clinical mastitis in dairy cattle – importance and causes

Authors

A.-S. Grieger

¹Mikrobiologie, Abteilung Bioverfahrenstechnik, Fakultät II, Hochschule Hannover

²Klinik für Rinder, Stiftung Tierärztliche Hochschule Hannover
V. Zoche-Golob

¹Mikrobiologie, Abteilung Bioverfahrenstechnik, Fakultät II, Hochschule Hannover
J.-H. Paduch

¹Mikrobiologie, Abteilung Bioverfahrenstechnik, Fakultät II, Hochschule Hannover
M. Hoedemaker

²Klinik für Rinder, Stiftung Tierärztliche Hochschule Hannover
V. Krömker

¹Mikrobiologie, Abteilung Bioverfahrenstechnik, Fakultät II, Hochschule Hannover

Abstract

Zusammenfassung

Klinische Mastitiden, die häufig als Rezidive auftreten, können in Milchviehbetrieben bedeutende ökonomische Verluste verursachen. Rezidivierende Mastitiden sind entweder auf persistierende Infek tionen der bovinen Milchdrüse mit einem Mastitiserreger oder auf Neuinfektionen von Eutervierteln nach einer bakteriologischen Ausheilung zurückzuführen. Sowohl die Virulenzeigenschaften eines Mastitiserregers als auch die tierindividuellen Heilungschancen können die Entstehung persistierender Infektionen der Milchdrüse maßgeblich beeinflussen, in deren Verlauf symptomfreie Perioden und klinische Episoden häufig im Wechsel auftreten. Strategien zur Reduzierung des Auftretens rezidivierender Mastitisfälle müssen verbesserte thera peutische Konzepte oder/und die Reduzierung der Neuinfektionsraten beinhalten. In der Literaturübersicht werden die wesentlichen Erkenntnisse zu Definitionen, Häufigkeiten, Ursachen und Auswirkungen rezidivierender Mastitiden dargestellt.

Summary

Clinical mastitis as a frequently recurrent event can cause substantive economic loss on dairy farms. The reason for recurrent mastitis can be either a persistent infection of the bovine mammary gland by a mastitis pathogen or a reinfection of a quarter or udder after bacteriological cure. The virulence properties of a mastitis pathogen and the cure odds of an individual cow determine the development of persistent infections. Clinical episodes may alternate with periods without symptoms in the course of persistent infections. Strategies to reduce cases of recurrent mastitis have to include improved treatment concepts and measures to decrease new infection rates. The present literature review summarises the knowledge of definitions, frequencies, causes and effects of recurrent mastitis.

Schlüsselwörter

Eutergesundheit - Rezidiv - persistierende Infektion - ökonomische Bedeutung

Key words

Udder health - recurrence - persistent infection - economic impact

Full Text

References

Literatur
1 Almeida RA, Dogan B, Klaessing S, Schukken YH, Oliver SP. Intracellular fate of strains of Escherichia coli isolated from dairy cows with acute or chronic mastitis. Vet Res Commun 2011; 35: 89-101.
2 Anderl JN, Zahller J, Roe F, Stewart PS. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2003; 47: 1251-1256.
3 Apparao MD, Ruegg PL, Lago A, Godden S, Bey R, Leslie K. Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodium. J Dairy Sci 2009; 92: 2589-2597.
4 Bar D, Grohn YT, Bennett G, Gonzalez RN, Hertl JA, Schulte HF, Tauer LW, Welcome FL, Schukken YH. Effect of repeated episodes of generic clinical mastitis on milk yield in dairy cows. J Dairy Sci 2007; 90: 4643-4653.
5 Bar D, Grohn YT, Bennett G, Gonzalez RN, Hertl JA, Schulte HF, Tauer LW, Welcome FL, Schukken YH. Effects of repeated episodes of generic clinical mastitis on mortality and culling in dairy cows. J Dairy Sci 2008; 91: 2196-2204.
6 Bar D, Tauer LW, Bennett G, Gonzalez RN, Hertl JA, Schukken YH, Schulte HF, Welcome FL, Grohn YT. The cost of generic clinical mastitis in dairy cows as estimated by using dynamic programming. J Dairy Sci 2008; 91: 2205-2214.
7 Barkema HW, Schukken YH, Lam TJ, Beiboer ML, Wilmink H, Benedictus G, Brand A. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J Dairy Sci 1998; 81: 411-419.
8 Barnhart MM, Chapman MR. Curli biogenesis and function. Annu Rev Microbiol 2006; 60: 131-147.
9 Boland T, Latour RA, Stutzenberger FJ. Molecular basis of bacterial adhesion. In: Handbook of Bacterial Adhesion. Principles, Methods, and Applications. An YN, Friedman RJ. eds. Humana Press; 2000: 29-41.
10 Bradley AJ, Green MJ. Adaptation of Escherichia coli to the bovine mammary gland. J Clin Microbiol 2001; 39: 1845-1849.
11 Clarke SR, Foster SJ. Surface adhesins of Staphylococcus aureus . Adv Microb Physiol 2006; 51: 187-224.
12 Costa JC, Espeschit Ide F, Pieri FA, Benjamin Ldos A, Moreira MA. Increased production of biofilms by Escherichia coli in the presence of enrofloxacin. Vet Microbiol 2012; 160: 488-490.
13 Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-1322.
14 Cucarella C, Tormo MÁ, Úbeda C, Trotonda MP, Monzón M, Peris C, Amorena B, Lasa Í, Penadés JR. Role of biofilm-associated protein bap in the pathogenesis of bovine Staphylococcus aureus . Infect Immun 2004; 72: 2177-2185.
15 Crowley RC, Leigh JA, Ward PN, Lappin-Scott HM, Bowler LD. Differential protein expression in Streptococcus uberis under planktonic and biofilm growth conditions. Appl Environ Microbiol 2011; 77: 382-384.
16 Dogan B, Klaessig S, Rishniw M, Almeida RA, Oliver SP, Simpson K, Schukken YH. Adherent and invasive Escherichia coli are associated with persistent bovine mastitis. Vet Microbiol 2006; 116: 270-282.
17 Döpfer D, Barkema HW, Lam TJGM, Schukken YH, Gaastra W. Recurrent clinical mastitis caused by Escherichia coli in dairy cows. J Dairy Sci 1999; 82: 80-85.
18 Döpfer D, Almeida RA, Lam TJGM, Nederbragt H, Oliver SP, Gaastra W. Adhesion and invasion of Escherichia coli from single and recurrent clinical cases of bovine mastitis in vitro. Vet Microbiol 2000; 74: 331-343.
19 Dyer JG, Sriranganathan N, Nickerson SC, Elvinger F. Curli production and genetic relationships among Escherichia coli from cases of bovine mastitis. J Dairy Sci 2007; 90: 193-201.
20 Gröhn YT, Wilson DJ, Gonzalez RN, Hertl JA, Schulte H, Bennett G, Schukken YH. Effect of pathogen-specific clinical mastitis on milk yield in dairy cows. J Dairy Sci 2004; 87: 3358-3374.
21 Heikkilä AM, Nousiainen JI, Pyörälä S. Costs of clinical mastitis with special reference to premature culling. J Dairy Sci 2012; 95: 139-150.
22 Hertl JA, Schukken YH, Bar D, Bennett GJ, González RN, Rauch BJ, Welcome FL, Tauer LW, Gröhn YT. The effect of recurrent episodes of clinical mastitis caused by gram-positive and gram-negative bacteria and other organisms on mortality and culling in Holstein dairy cows. J Dairy Sci 2011; 94: 4863-4877.
23 Hillerton JE, Kliem KE. Effective treatment of Streptococcus uberis clinical mastitis to minimize the use of antibiotics. J Dairy Sci 2002; 85: 1009-1014.
24 Houben EHP, Dijkhuizen AA, Van Arendonk JAM, Huirne R. Short- and long-term production losses and repeatability of clinical mastitis in dairy cattle. J Dairy Sci 1993; 76: 2561-2578.
25 Kelton DF, Lissemore KD, Martin RE. Recommendations for recording and calculating the incidence of selected clinical diseases of dairy cattle. J Dairy Sci 1998; 81: 2502-2509.
26 Lam TJGM, Lipman LJA, Schukken YH, Gaastra W, Brand A. Epidemiological characteristics of bovine clinical mastitis caused by Staphylococcus aureus and Escherichia coli studied by DNA fingerprinting. Am J Vet Res 1996; 57: 39-42.
27 Lehtolainen T, Pohjanvirta T, Pyörälä S, Pelkonen S. Association between virulence factors and clinical course of Escherichia coli mastitis. Acta Vet Scand 2003; 44: 203-205.
28 Melchior MB, Vaarkamp H, Fink-Gremmels J. Biofilms: a role in recurrent mastitis infections?. Vet J 2006; 171: 398-407.
29 Melchior MB. Bovine mastitis and biofilms. In: Biofilms and Veterinary Medicine. Percival SL, Knottenbelt DC, Cochrane CA. eds. Heidelberg, Dordrecht, London, New York: Springer; 2011: 205-221.
30 Oliviera M, Nunes SF, Carneiro C, Bexiga R, Bernardo F, Vilela CL. Time course of biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis mastitis isolates. Vet Microbiol 2007; 124: 187-191.
31 Percival SL, Malic S, Cruz H, Williams DW. Introduction to biofilms. In: Biofilms and Veterinary Medicine. Springer Series on Biofilms. Volume 6. Costerton JW, Percival SL, Cochrane CA, Knottenbelt DC. eds. Berlin, Heidelberg: Springer; 2011: 41-68.
32 Petrovski KR, Trajcev M, Buneski G. A review of the factors affecting the costs of bovine mastitis as review article. J S Afr Vet Assoc 2012; 77: 52-60.
33 Pinzón-Sánchez C, Ruegg PL. Risk factors associated with short-term post-treatment outcomes of clinical mastitis. J Dairy Sci 2011; 94: 3397-3410.
34 Prakash B, Veeregowda BM, Krishnappa G. Biofilms: a survival strategy of bacteria. Curr Sci 2003; 85: 1299-1307.
35 Schukken YH, Hertl J, Bar D, Bennett GJ, Gonzalez RN, Rauch BJ, Santisteban C, Schulte HF, Tauer L, Welcome FL, Gröhn YT. Effects of repeated gram-positive and gram-negative clinical mastitis episodes on milk yield loss in Holstein dairy cows. J Dairy Sci 2009; 92: 3091-3105.
36 Schukken YH, Bar D, Hertl J, Gröhn YT. Correlated time to event data: modeling repeated clinical mastitis data from dairy cattle in New York State. Prev Vet Med 2010; 97: 150-156.
37 Simojoki H, Hyvönen P, Pumed Ferrer C, Taponen S, Pyörälä S. Is the biofilm formation and slime producing ability of coagulase-negative staphylococci associated with the persistence and severity of intramammary infections?. Vet Microbiol 2012; 158: 344-352.
38 Steeneveld W, Hogeveen H, Barkema HW, van den Broek J, Huirne RBM. The influence of cow factors on the incidence of clinical mastitis in dairy cows. J Dairy Sci 2008; 91: 1391-1402.
39 Thurlow LR, Hanke ML, Fritz T, Angle A, Aldrich A, Williams SH, Engebretsen IL, Bayles KW, Horswill AR, Kielian T. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol 2011; 186: 6585-6596.
40 Wenz JR, Garry FB, Lombard JE, Elia R, Prentice D, Dinsmore RP. Short Communication: Efficacy of parenteral ceftiofur for treatment of systemically mild clinical mastitis in dairy cattle. J Dairy Sci 2005; 88: 3496-3499.
41 Wolfová M, Stípková M, Wolf J. Incidence and economics of clinical mastitis in five Holstein herds in the Czech Republic. Prev Vet Med 2006; 77: 48-64.
42 Zadoks RN, Allore HG, Barkema HW, Sampimon OC, Wellenberg GJ, Grohn YT, Schukken YH. Cow- and quarter-level risk factors for Streptococcus uberis and Staphylococcus aureus mastitis. J Dairy Sci 2001; 84: 2649-2663.
43 Zoche-Golob V, Spilke J. Herdenspezifische Schätzung der Milchleistungsminderung durch wiederholte klinische Mastitis. Berl Münch Tierärztl Wochenschr 2013; 126: 269-276.
44 Zoche-Golob V. Persönliche Mitteilung..